share_log

Marker Therapeutics | PREM14A: Preliminary proxy statements relating to merger or acquisition

SEC ·  Jul 14, 2018 05:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more